Recombinant Human TRIM72 Protein，His

TRIM72, a member of the TRIM (tripartite motif-containing) protein family, has gained significant attention in recent years due to its pivotal role in various biological processes, including muscle development, metabolism, and cellular stress response. Initially discovered for its involvement in skeletal muscle homeostasis, TRIM72 has been found to modulate autophagy and act as a critical regulator of inflammation and immune responses. The protein's unique structural features, characterized by a RING domain, two B-boxes, and a coiled-coil region, facilitate its function as an E3 ubiquitin ligase, allowing it to regulate protein turnover by tagging substrates for degradation. Given the association of TRIM72 dysfunction with several conditions, including muscular dystrophies and metabolic disorders, researchers are increasingly focusing on the therapeutic potential of TRIM72. Recombinant TRIM72 protein studies enable a deeper understanding of its molecular mechanisms, effects on cellular pathways, and potential as a biomarker or therapeutic target. Investigations utilizing TRIM72 reconstitution models highlight the implications of its activity in modulating key signaling pathways, offering insights into muscle regeneration and immune modulation. As research continues to elucidate the multifaceted roles of TRIM72, it presents exciting possibilities for developing novel strategies in treating related diseases, underscoring the significance of this protein in health and disease.